Using Spatial Technology for Immuno-Oncology Antibody Development

Time: 2:00 pm
day: Day Two

Details:

• Detecting target expression in specific cell types in FFPE tumors

• T-cell pharmacodynamics and activation states in patients treated with PD1 inhibitor

• In-situ T-cell receptor diversity estimation to understand antigen specificity in the tumor microenvironment 

Speakers: